Authors : Dr. Junior Sundresh N.; Shivabharath R.; Sheeba D.

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/4kfn2u9p

Scribd : https://tinyurl.com/43hyakej

DOI : https://doi.org/10.38124/ijisrt/25aug773

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Cellulitis, a common bacterial skin infection, often necessitates prompt antibiotic treatment. Ciprofloxacin, a broad-spectrum fluoroquinolone available in both oral and intravenous (IV) forms, offers flexibility in therapy, though the comparative effectiveness and safety of these routes in cellulitis management remain underexplored. This prospective study, conducted at Government Medical College and Hospital, Chidambaram, aimed to compare the clinical efficacy, safety, and cost-effectiveness of oral versus IV ciprofloxacin in cellulitis treatment. Patients diagnosed with cellulitis received either oral or IV ciprofloxacin, with data collected on demographics, clinical features, treatment duration, time to clinical improvement, hospital stay, adverse events, and treatment outcomes. Results showed that both forms were similarly effective in resolving cellulitis, with no significant differences in clinical improvement or recurrence rates. However, the oral group experienced shorter hospital stays and lower treatment costs, with a low and comparable incidence of adverse effects in both groups. The study concludes that oral ciprofloxacin is as effective and safe as IV administration in selected patients, making it a cost- efficient and convenient first-line treatment option for cellulitis.

Keywords : Ciprofloxacin, Cellulitis, Fluoroquinolones, Recurrence, Oral Therapy, Intravenous Therapy.

References :

1. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2014;59(2): e10–52.
2. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: Expert panel recommendations on appropriate antimicrobial therapy. The American Journal of Medicine. 2003;114(5):451–8.
3. Brindle R, Williams OM, Featherstone P. Assessment of antibiotic treatment for cellulitis and erysipelas: a systematic review and meta-analysis. JAMA Dermatology. 2019;155(9):1033–40.
4. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC Jr, Craig WA, Billeter M, et al. Therapeutic monitoring of vancomycin: A revised consensus guideline. American Journal of Health-System Pharmacy. 2009;66(1):82–98.
5. Nathwani D, Dryden M, Garau J. Early switch from intravenous to oral antibiotics: criteria for decision-making and clinical outcomes in soft tissue infections. Journal of Global Antimicrobial Resistance. 2016; 4:141–6.
6. Cross ELA, Jordan H, Godfrey R, Onakpoya IJ, Shears A, Fidler K, et al. Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of effectiveness and harms. The Journal of Infection. 2020;81(4):521–31.
7. Gonçalves-Pereira J, Silva A, Pereira J. Oral versus intravenous antibiotics for lower limb cellulitis: systematic review and meta-analysis. Clinical Microbiology and Infection. 2022;28(10):1382–90.
8. Collazos J, de la Fuente B, García A, Gómez H, Menéndez C, Enríquez H, et al. Cellulitis in adult patients: a large, multicentre, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS ONE. 2018;13(9): e0204036.
9. Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infection & Chemotherapy. 2017;49(4):301–25.
10. Pallasch TJ, Slots J. Pharmacokinetic and pharmacodynamic rationale for the use of oral antibiotics in skin and soft tissue infections. International Journal of Antimicrobial Agents. 2023;61(2):106812.
11. Yin R, Jiang J, Wang Y, Jin Y, Qian E, Yue C, et al. Comparing oral versus intravenous antibiotics administration for cellulitis infection: protocol for a systematic review and meta-analysis. JMIR Research Protocols. 2023;12: e48342.
12. Spellberg B, Rice LB. Duration of antibiotic therapy: shorter is better. JAMA Internal Medicine. 2019;179(2):225–6.
13. Santer M, Lalonde A, Francis NA, Smart P, Hooper J, Teasdale E, et al. Management of cellulitis: current practice and research questions. The British Journal of General Practice. 2018;68(677):595–6.
14. Badar V, Chavan RR, Chokhandre M, Pradhan K. Evaluation of disease distribution and drug utilization for management of psoriasis patients in dermatology OPD of a tertiary care centre: a retrospective observational study. International Journal of Research in Medical Sciences. 2023;11(3):797–802.